Restless legs syndrome in end-stage renal disease: A multicenter study in Taiwan

European Journal of Neurology

Volumn 20, Issue 7, 2013, Pages 1025-1031

  Lin, C H ^a   Wu, V C ^a   Li, W Y ^a   Sy, H N ^b   Wu, S L ^b   Chang, C C ^b   Chiu, P F ^b   Lion, H H ^c   Lin, C Y ^d   Chang, H W ^e   Lin, S Y ^a   Wu, K D ^a   Chen, Y M ^a   Wu, R M ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c Hsin Jen Hospital   (Taiwan)

^d EN CHU KONG HOSPITAL   (Taiwan)

^e Far Eastern Polyclinic   (Taiwan)

Author keywords

Diabetes; Dialysis; End stage renal disease; Restless legs syndrome

Indexed keywords

HEMOGLOBIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RISK FACTOR; SLEEP QUALITY; TAIWAN; TRANSFERRIN BLOOD LEVEL; TREATMENT DURATION; UREMIA;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RESTLESS LEGS SYNDROME; RISK FACTORS; TAIWAN;

EID: 84879024999     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12095     Document Type: Article

References (45)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-109.
2. Tan EK, Seah A, See SJ, Lim E, Wong MC, Koh KK. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001; 16: 577-579.
3. Chen NH, Chuang LP, Yang CT, et al. The prevalence of restless legs syndrome in Taiwanese adults. Psychiatry Clin Neurosci 2010; 64: 170-178.
4. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev 2010; 6: 337-346.
5. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996; 28: 372-378.
6. Takaki J, Nishi T, Nangaku M, et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis 2003; 41: 833-839.
7. Gigli GL, Adorati M, Dolso P, et al. Restless legs syndrome in end-stage renal disease. Sleep Med 2004; 5: 309-315.
8. Araujo SM, de Bruin VM, Nepomuceno LA, et al. Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med 2010; 11: 785-790.
9. Molnar MZ, Novak M, Ambrus C, et al. Restless Legs Syndrome in patients after renal transplantation. Am J Kidney Dis 2005; 45: 388-396.
10. La Manna G, Pizza F, Persici E, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant 2011; 26: 1976-1983.
11. Merlino G, Lorenzut S, Gigli GL, et al. A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure. Mov Disord 2010; 25: 1019-1025.
12. Kim JM, Kwon HM, Lim CS, et al. Restless legs syndrome in patients on hemodialysis: symptom severity and risk factors. J Clin Neurol 2008; 4: 153-157.
13. United States Renal Data System: USRDS. Annual Data Report. Bethesda, MD:The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2007.
14. Kuo HW, Tsai SS, Tiao MM, et al. Analgesic use and the risk for progression of chronic kidney disease. Pharmacoepidemiol Drug Saf 2010; 19: 745-751.
15. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-132.
16. Tsai PS, Wang SY, Wang MY, et al. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res 2005; 14: 1943-1952.
17. Merlino G, Fratticci L, Valente M, et al. Association of restless legs syndrome in type 2 diabetes: a case-control study. Sleep 2007; 30: 866-871.
18. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes Care 2011; 34: 1102-1108.
19. Sun Y, Chang YH, Chen HF, Su YH, Su HF, Li CY. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care 2012; 35: 1047-1049.
20. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004; 3: 169-178.
21. Earley CJ, Heckler D, Allen RP. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med 2005; 6: 301-305.
22. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001; 16: 335-340.
23. Salman SM. Restless legs syndrome in patients on hemodialysis. Saudi J Kidney Dis Transpl 2011; 22: 368-372.
24. Pizza F, Persici E, La Manna G, et al. Family recurrence and oligo-anuria predict uremic restless legs syndrome. Acta Neurol Scand 2012; 125: 403-409.
25. Hornyak M, Trenkwalder C, Kohnen R, Scholz H. Efficacy and safety of dopamine agonists in restless legs syndrome. Sleep Med 2012; 13: 228-236.
26. Buchfuhrer MJ.Strategies for the treatment of Restless Legs Syndrome. Neurotherapeutics 2012; 9: 776-790.
27. de Oliveira MM, Conti CF, Valbuza JS, de Carvalho LB, do Prado GF. The pharmacological treatment for uremic Restless Legs Syndrome: evidence-based review. Mov Disord 2010; 25: 1335-1342.
28. García-Borreguero D, Oertel W. SP710 study group. Treatment of restless legs syndrome with rotigotine. Lancet Neurol 2011; 10: 872-873.
29. Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M. Dopamine agonists for restless legs syndrome. Cochrane Database Syst Rev 2011; 3: CD006009.
30. Trenkwalder C, Stiasny K, Pollmacher T, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995; 18: 681-688.
31. Ibrahim JM, Wegdan OM. Epidemiology of sleep disorders in patients with chronic renal disease in Cairo. J Egypt Public Health Assoc 2011; 86: 68-72.
32. Sabry AA, Abo-Zenah H, Wafa E, et al. Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transpl 2010; 21: 300-305.
33. Zilberman M, Silverberg DS, Schwartz D, Oksenberg A. Restless legs syndrome (RLS) in anemic patients with congestive heart failure and chronic renal failure: lack of effect of anemia treatment. Int J Cardiol 2010; 143: 205-207.
34. Al-Jahdali HH, Al-Qadhi WA, Khogeer HA, Al-Hejaili FF, Al-Ghamdi SM, Al Sayyari AA. Restless legs syndrome in patients on dialysis. Saudi J Kidney Dis Transpl 2009; 20: 378-385.
35. Loewen A, Siemens A, Hanly P. Sleep disruption in patients with sleep apnea and end-stage renal disease. J Clin Sleep Med 2009; 5: 324-329.
36. Bastos JP, Sousa RB, Nepomuceno LA, et al. Sleep disturbances in patients on maintenance hemodialysis: role of dialysis shift. Rev Assoc Med Bras 2007; 53: 492-496.
37. Kawauchi A, Inoue Y, Hashimoto T, et al. Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory data analysis. Clin Nephrol 2006; 66: 440-446.
38. Merlino G, Piani A, Dolso P, et al. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 2006; 21: 184-190.
39. Mucsi I, Molnar MZ, Ambrus C, et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 2005; 20: 571-577.
40. Bhowmik D, Bhatia M, Gupta S, Agarwal SK, Tiwari SC, Dash SC. Restless legs syndrome in hemodialysis patients in India: a case controlled study. Sleep Med 2003; 4: 143-146.
41. Hui DS, Wong TY, Li TS, et al. Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis. Med Sci Monit 2002; 8: 331-336.
42. Thorp ML, Morris CD, Bagby SP. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis 2001; 38: 104-108.
43. Miranda M, Araya F, Castillo JL, Duran C, Gonzalez F, Aris L. Restless legs syndrome: a clinical study in adult general population and in uremic patients. Rev Med Chil 2001; 129: 179-186.
44. Hui DS, Wong TY, Ko FW, et al. Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 36: 783-788.
45. Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 1998; 31: 324-328.